FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing

AIMS: FOCUS4 was a phase II/III umbrella trial, recruiting patients with advanced or metastatic colorectal cancer, between 2014 and 2020. Molecular profiling of patients’ formalin-fixed, paraffin-embedded tumour blocks was undertaken at two centralised biomarker laboratories (Leeds and Cardiff), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Richman, Susan D, Hemmings, Gemma, Roberts, Helen, Gallop, Niall, Dodds, Rachel, Wilkinson, Lyndsay, Davis, Jonathan, White, Rhian, Yates, Emma, Jasani, Bharat, Brown, Louise, Maughan, Tim S, Butler, Rachel, Quirke, Philip, Adams, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614788/
https://www.ncbi.nlm.nih.gov/pubmed/35256486
http://dx.doi.org/10.1136/jclinpath-2022-208233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614788/
https://www.ncbi.nlm.nih.gov/pubmed/35256486
http://dx.doi.org/10.1136/jclinpath-2022-208233

Ejemplares similares